Holders over time
- TMO
- GILD
| Quarter | TMO | GILD |
|---|---|---|
| Q4 2020 | 33 holders, $39.2bn | 27 holders, $13.4bn |
| Q1 2021 | 35 holders, $36.5bn | 24 holders, $14.5bn |
| Q2 2021 | 33 holders, $38.3bn | 18 holders, $14.9bn |
| Q3 2021 | 32 holders, $42.6bn | 20 holders, $16.4bn |
| Q4 2021 | 38 holders, $50.1bn | 20 holders, $16.8bn |
| Q1 2022 | 32 holders, $43.2bn | 28 holders, $13.2bn |
| Q2 2022 | 33 holders, $38.9bn | 26 holders, $13.6bn |
| Q3 2022 | 26 holders, $34.3bn | 24 holders, $13.3bn |
| Q4 2022 | 29 holders, $37.0bn | 32 holders, $21.1bn |
| Q1 2023 | 35 holders, $37.1bn | 27 holders, $21.8bn |
| Q2 2023 | 39 holders, $33.5bn | 24 holders, $20.7bn |
| Q3 2023 | 39 holders, $32.6bn | 24 holders, $20.0bn |
| Q4 2023 | 41 holders, $32.7bn | 22 holders, $21.5bn |
| Q1 2024 | 30 holders, $34.1bn | 30 holders, $20.3bn |
| Q2 2024 | 38 holders, $30.6bn | 28 holders, $18.5bn |
| Q3 2024 | 30 holders, $33.8bn | 29 holders, $24.2bn |
| Q4 2024 | 36 holders, $27.6bn | 28 holders, $25.9bn |
| Q1 2025 | 31 holders, $24.2bn | 33 holders, $32.0bn |
| Q2 2025 | 39 holders, $18.8bn | 27 holders, $30.9bn |
| Q3 2025 | 32 holders, $21.9bn | 23 holders, $29.4bn |
| Q4 2025 | 32 holders, $29.9bn | 25 holders, $34.3bn |
| Q1 2026 | 34 holders, $24.4bn | 25 holders, $38.5bn |
| Q2 2026 | 36 holders, $26.4bn | 26 holders, $34.2bn |
| Q3 2026 | 35 holders, $40.3bn | 31 holders, $38.6bn |
Thermo Fisher Scientific Inc
- Holders
- 38
- Reported value
- $30.6bn
- Buyers
- 25
- Sellers
- 18
Breadth +7 among 94 comparable managers.
Gilead Sciences Inc
- Holders
- 28
- Reported value
- $18.5bn
- Buyers
- 15
- Sellers
- 14
Breadth +1 among 94 comparable managers.
Who holds both, Q2 2024
Both (23)
Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, D. E. Shaw & Co., Dodge & Cox, Eisler Capital Management Ltd, Fidelity (FMR LLC), Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Millennium Management LLC, Point72 Asset Management LP, Renaissance Technologies LLC, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Tudor Investment Corp, Two Sigma Advisers LP, Two Sigma Investments LP, Wellington Management Group LLP, Winton Group Ltd
Only TMO (15)
Baillie Gifford & Co, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Citadel Advisors LLC, Farallon Capital Management LLC, GAMCO Investors Inc, Holocene Advisors LP, Jane Street Group LLC, Markel Group Inc, MFS Investment Management, Neuberger Berman Group LLC, Polen Capital Management LLC, Quantbot Technologies LP, Verition Fund Management LLC, Walleye Capital LLC
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.